EMA Launches Strategy To Test If Patient Registries Can Better Support Regulatory Decision-Making
This article was originally published in SRA
Executive Summary
The European Medicines Agency has launched an initiative aimed at making better use of existing patient registries to generate high-quality post-authorization data to support regulatory decision-making, and to facilitate the establishment of new registries if needed1.